Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Surgery Vs Primary Chemoradiation for Oropharyngeal Cancer (Scope Trial) - A Phase II/III Integrated Design Randomized Control Trial

NCT05144100 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT05144100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05144100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Surgery Vs Primary Chemoradiation for Oropharyngeal Cancer (Scope Trial) - A Phase II/III Integrated Design Randomized Control Trial
Lead sponsor
Tata Memorial Centre
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
December 1, 2021
Completion date
June 30, 2031
Enrollment
498 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii oropharyngeal (p16-negative) carcinoma ajcc v8, stage iv oropharyngeal (p16-negative) carcinoma ajcc v8